‘Tobacco-Flavored’ E-Cigarette Liquids Now More Sweet, Fruity

MONDAY, Nov. 7, 2022 (HealthDay News) -- The use of sweet and fruity flavor chemicals in tobacco-flavored electronic cigarette liquids (e-liquids) has increased, according to a study published online Nov. 3 in Tobacco Control.
Esther E. Omaiye, Ph.D., from the University of California in Riverside, and colleagues examined the evolving composition of tobacco-flavored e-liquids during the last 10 years.
The researchers found that tobacco-flavored products purchased in 2010 and 2011 generally had very few flavor chemicals, and their concentrations were generally very low. However, for tobacco-flavored refill fluids purchased in 2019 and Puff Bar Tobacco e-cigarettes, the total number and concentration of flavor chemicals were higher. Products with total flavor chemicals >10 mg/mL contained one to five dominant flavor chemicals (>1 mg/mL), with fruity and caramellic identified as the most frequently used flavor chemicals in tobacco-flavored e-liquids.
"There has been a recent stealth use of high concentrations of sweet and fruity confectionery-related flavor chemicals in 'tobacco-flavored' e-liquids. This change in tobacco e-liquid ingredients coincides with restrictions on the sale of sweet and fruity-flavored products," the authors write. "There is a need for continued surveillance of e-liquids, particularly tobacco flavored, which may be manipulated to circumvent policies on flavor use."
Related Posts
Skipping Radiation May Be Safe for Some With Early Breast Cancer
THURSDAY, Aug. 17, 2023 (HealthDay News) -- Many women with early breast cancer...
Disney Princesses: Are They Good or Bad for Your Child’s Self-Image?
WEDNESDAY, Sept. 13, 2023 (HealthDay News) -- For parents worried about how...
DDW: Endoscopic Procedure May Eliminate Insulin Use in T2DM
TUESDAY, May 2, 2023 (HealthDay News) -- Recellularization via electroporation...
Pfizer comienza a evaluar una vacuna contra la COVID dirigida a la ómicron
MARTES, 25 de enero de 2022 (HealthDay News) -- Pfizer Inc. anunció el martes...